Molecular Diagnostics Market

Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1185
  • Published On : Aug 2013
  • No. of Pages : 96
  • Category : Healthcare

Table of Content
 
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019)
2.2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million)
2.3 Global Molecular Cytogenetics Market, by Application, 2012 (USD Million)
 
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
      3.2.1 Introduction of advanced technologies
      3.2.2 Rising incidence of cancer cases
3.3 Market Restraints
      3.3.1 Issues with medical reimbursement
3.4 Market Opportunities
      3.4.1 Advent of Next Generation Sequencing
      3.4.2 Tapping the emerging economies
3.5 Porter’s Five Forces Analysis
      3.5.1 Bargaining power of buyers
      3.5.2 Bargaining power of suppliers
      3.5.3 Threat of new entrants
      3.5.4 Threat of substitutes
      3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis
3.7 Market Share Analysis, by Key Players (%)
      3.7.1 Global Molecular Cytogenetics Market Share Analysis, by Key Players (%)
3.8 End User Analysis
      3.8.1 Global Molecular Cytogenetics End User Analysis
 
Chapter 4 Molecular Cytogenetics Market, by Technology
4.1 Overview
      4.1.1 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
4.2 Fluorescence in situ hybridization (FISH)
      4.2.1 Global FISH Market, 2011 – 2019 (USD Million)
4.3 Array-Comparative Genomic Hybridization (aCGH)
      4.3.1 Global aCGH Market, 2011 – 2019 (USD Million)
 
Chapter 5 Molecular Cytogenetics Market, by Applications
5.1 Overview
      5.1.1 Global Molecular Cytogenetics Market, by Application, 2011 – 2019 (USD Million)
5.2 Cancer
      5.2.1.1 Global Cancer Application Market, 2011 – 2019 (USD Million)
5.3 Personalized Medicines
      5.3.1.1 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million)
5.4 Genetic Disorders
      5.4.1.1 Global Genetic Disorder Application Market, 2011 – 2019 (USD Million)
5.5 Others (Neurological, Cardiovascular and Infectious Diseases)
      5.5.1.1 Global Others Application Market, 2011 – 2019 (USD Million)
 
Chapter 6 Molecular Cytogenetics Market, by Geography
6.1 Overview
      6.1.1 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
      6.3.1 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
      6.3.2 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
6.4 Europe
      6.4.1 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
      6.4.2 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
      6.5.1 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
      6.5.2 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
6.6 RoW
      6.6.1 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
      6.6.2 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
 
Chapter 7 Recommendations
7.1 Investment in emerging economies
7.2 Mergers and Acquisitions
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Affymetrix, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategy
      8.2.5 Recent Developments
8.3 Agilent Technologies, Inc.
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Applied Spectral Imaging, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategy
8.5 BI Biological Industries
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategy
8.6 Bio-Rad Laboratories
      8.6.1 Company overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 CytoTest Inc.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategy
8.8 Cytognomix, Inc.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Recent Developments
8.9 F. Hoffmann-La Roche Ltd.
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategy
      8.9.5 Recent Developments
8.10 Illumina Inc.
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 LEICA BIOSYSTEMS
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategy
      8.11.5 Recent Development
8.12 Life Technologies Corporation
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategy
      8.12.5 Recent Developments
8.13 Oxford Gene Technology
      8.13.1 Company Overview
      8.13.2 Financial Overview
      8.13.3 Product Portfolio
      8.13.4 Business Strategy
      8.13.5 Recent Developments
8.14 PerkinElmer, Inc.
      8.14.1 Company Overview
      8.14.2 Financial Overview
      8.14.3 Product Portfolio
      8.14.4 Business Strategy
      8.14.5 Recent Developments
8.15 SciGene Corporation
      8.15.1 Company Overview
      8.15.2 Financial Overview
      8.15.3 Product Portfolio

List of Tables
 
TABLE 1 Market Snapshot: Global Molecular Cytogenetics Market (2012 & 2019)
TABLE 2 Global Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 3 Global Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Molecular Cytogenetics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 6 North America Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 8 Europe Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Molecular Cytogenetics Market, by Technology, 2011 – 2019 (USD Million)
TABLE 12 RoW Molecular Cytogenetics Market, by Applications, 2011 – 2019 (USD Million)

List of Figures
 
FIG. 1 Molecular Cytogenetics: Market Segmentation
FIG. 2 Global Molecular Cytogenetics Market, by Technology, 2012 (USD Million)
FIG. 3 Global Molecular Cytogenetics Market, by Applications, 2012 (USD Million)
FIG. 4 Porter’s Five Forces Analysis: Global Molecular Cytogenetics Market
FIG. 5 Market Attractiveness Analysis: Global Molecular Cytogenetics Market, by Geography
FIG. 6 Molecular Cytogenetics: Market Share, by Key Players, 2012 (%)
FIG. 7 Molecular Cytogenetics: End User Analysis, 2012
FIG. 8 FISH Procedural Steps
FIG. 9 Global FISH Market, 2011 – 2019 (USD Million)
FIG. 10 Global aCGH Market, 2011 – 2019 (USD Million)
FIG. 11 Global Cancer Application Market, 2011 – 2019 (USD Million)
FIG. 12 Global Personalized Medicine Application Market, 2011 – 2019 (USD Million)
FIG. 13 Global Genetic Disorders Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Others Applications Market, 2011 – 2019 (USD Million)
FIG. 15 Comparative Analysis: Molecular Cytogenetics Market, by Geography, 2012 & 2019 (Value %)
FIG. 16 Abbott Laboratories, Annual Revenues: 2010 – 2012 (USD Billion)
FIG. 17 Affymetrix, Inc. Annual Revenues: 2010 – 2012 (USD Million)
FIG. 18 Agilent Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bio-Rad Laboratories, Annual Revenues: 2010 – 2012 (1 Euro = 1.32 USD) (USD Million)
FIG. 20 F. Hoffmann-La Roche Ltd., Annual Revenues: 2010 – 2012 (1 Swiss Franc = 1.09 USD) (USD Billion)
FIG. 21 Illumina Inc., Annual Revenues: 2010-2012 (USD Million)
FIG. 22 Life Technologies Corporation, Annual Revenues: 2010 – 2012 (USD Million)
FIG. 23 PerkinElmer Inc., Annual Revenues: 2010 – 2012 (USD Billion)

.